The Medicine Maker 2021 Power List is now live – and includes the top 20 most inspirational professionals in small molecules, biopharmaceuticals, and advanced medicine. The Power List is a celebration of the great and good in pharmaceutical development and manufacture. Take a look at the list here.
Putting together last year’s Power List in 2020 was a surreal experience; at the time, we were just getting to grips with how COVID-19 was affecting the world and changing our everyday lives. We faced a very uncertain future – especially as we all knew that new vaccine and drug development typically takes around ten years.
Now in 2021, lockdowns remain in place in many countries and the death toll continues to rise; approaching 3 million as of the start of April 2021. Severe lessons have been learned by governments that failed to respect the dangers of the virus. And pharma too has learned many lessons in terms of securing supply chains, adapting operations to suit social distancing, and working faster than ever before to research and develop new therapeutic options for a new virus.
The pandemic is not over – and won’t be for some time – but there are reasons to feel optimistic. Effective vaccines have been approved by various regulators for emergency use, existing drugs are being repurposed to help patients with severe COVID-19, and new drug development is vibrant. Small molecules, biopharmaceuticals, and even cell therapies are all being explored as potential medicines to combat COVID-19. The industry has genuinely outdone itself. And alongside interventions against COVID-19, others in the industry continue to work tirelessly to address other crucial areas.
Our 2021 Power List showcases just a small number of the brilliant professionals working tirelessly to solve some of the greatest drug development challenges. To compile the list, we asked visitors to our website to nominate inspirational people they wanted to see on the list; the nominations were then submitted to a judging panel.
What do you think of the 2021 Power List? I’d love to hear your thoughts at stephanie.sutton@texerepublishing.com
Formulation and Characterization Strategies for Gene Therapies
Gene therapy product formulation studies are currently limited in scope. Hear our expert discuss how we're working towards establishing formulation selection criteria using traditional techniques and evaluating novel methodologies.
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
